Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori

Archives of Internal Medicine

Volumn 157, Issue 1, 1997, Pages 87-97

  Taylor, Jennifer L ^a   Zagari, Martin ^a   Murphy, Karen ^a   Feston, James W ^b  

^a Technology Assessment Group   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH SALICYLATE; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; DRUG COST; DUODENUM ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENCE RISK; TREATMENT OUTCOME;

EID: 0031013026     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.1.87     Document Type: Article

References (123)

1. US Department of Health and Human Services. Stomach and Duodenal Ulcers. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases; 1995. National Institutes of Health publication 95-38.
2. Imperiale TF, Speroff T, Cebul RD, McCullough AJ. A cost analysis of alternative treatments for duodenal ulcer. Ann intern Med. 1995;123:665-672.
3. 2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection. J Gastroenterol. 1987;82:1242-1249.
4. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65-69.
5. Soil A. Medical treatment of peptic ulcer disease: practice guideline. JAMA. 1996;275:622-629.
6. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann intern Med. 1992;116:705-708.
7. Tytgat GNJ. Long-term consequences of Helicobacter pylori eradication. Scand J Gastroenterol. 1994;29(suppl 205):38-44.
8. Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet. 1994;343:258-260.
9. Borody TJ, Andrews P, Mancuso N, et al. Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer. Am J Gastroenterol. 1994;89:529-532.
10. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc. 1995;41:1-4.
11. Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar C-H. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc. 1995;41:5-7.
12. Sonnenberg A. Costs of medical and surgical treatment of duodenal ulcer. Gastroenterology. 1989;96:1445-1452.
13. Unge P, Ekström P. High dose amoxicillin plus omeprazole in eradicating H pylori. Gastroenterology. 1995;108:248. Abstract.
14. O'Brien B, Goeree R, Mohamed AH, et al. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. Arch Intern Med. 1995;155:1958-1964.
15. Vakil N, Fennerty MB. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. Am J Gastroenterol. 1996; 91:239-245.
16. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992;102:493-496.
17. Jacobs J, Bloom BS. Compliance and cost in NSAID therapy. Hosp Ther. 1987; 12(suppl):32-39.
18. McColl KE, el-Nujumi AM, Chittajallu RS, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut. 1993;34: 762-768.
19. HealthCare Consultants of America, Inc. Physicians Fee and Coding Guide. Augusta, Ga: HealthCare Consultants of America, Inc; 1995;39, 43, 319.
20. 1993 Hospital Discharge Database. Sacramento: State of California, Office of Statewide Health Planning and Development;1994.
21. Office of Statewide Health Planning and Development Data Users Support Group. Quarterly Aggregate Hospital Data for California, 4th Quarter, 1993. Sacramento: State of California, Office of Statewide Health Planning and Development; 1994.
22. Sonnenberg A, Townsend WF. Costs of duodenal ulcer therapy with antibiotics. Arch Intern Med. 1995;155:922-928.
23. Drug Topics, 1995 Red Book: Pharmacy's Fundamental Reference. Montvale, NJ: Medical Economics Co Inc; November 1995.
24. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical Decision Making. Stoneham. Mass: Butterworth-Heinemann; 1988:67-101.
25. Adamek RJ, Wegner M, Birkholz S, et al. Modified combined omeprazole/ amoxicillin therapy regimen for eradication of H pylori: a pilot study. Ir J Med Sci. 1992;161(suppl 10):90.
26. Adamek RJ, Wegener M, Labenz J, Freitag M, Oplerkuch W, Rühl GH. Medium-term results of oral and intravenous omeprazole amoxicillin Helicobacter pylori eradication therapy. Am J Gastroenterol. 1994;89:39-42.
27. Al-Assi MT, Cole RA, Karttunen TJ, El-Zimaity H, Genta RM, Graham DY. Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin. Am J Gastro- enterol. 1995;90:1411-1414.
28. Atherton JC, Hudson N, Kirk GE, Hawkey CK, Spiller RC. Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori: assessment of the importance of antibiotic dose timing in relation to meals. Aliment Pharmacol Ther. 1994;8:495-498.
29. Axon ATR. The role of omeprazole and antibiotic combinations in the eradication of Helicobacter pylori: an update. Scand J Gastroenterol. 1994;29 (Suppl 205):31-37.
30. Bank S, Blumstein M, Greenberg R, et al. Amoxicillin 1 gram TID when combined with omeprazole gives high H pylori eradication rates: preliminary report. Gastroenterology. 1995;108:52. Abstract.
31. Bardhan KD, Logan RPH, Celestin LR, et al. Clarithromycin (CL) and omeprazole (OM) in the prevention of duodenal ulcer (DU) recurrence and eradication of Helicobacter pylori (H pylori). Gastroenterology. 1995;108:53. Abstract.
32. Bell GD, Powell KU, Burridge SM, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 1995;9:41-46.
33. Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med. 1993;86: 743-750.
34. Bell GD, Powell KU, Burridge SM, et al. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori Aliment Pharmacol Ther. 1992;6:751-758.
35. Borody TJ, Andrews P, Fracchia G, Brandi S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut. 1995; 37:477-481.
36. Borody TJ, Andrews P, Shortis NP, Hyland L. 7 Day therapy for Helicobacter pylori. Gastroenterology. 1995;108:62. Abstract.
37. Borody TJ, Brandi S, Andrews P, Ferch N, Jankiewicz E, Hyland L. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol. 1994;89:33-38.
38. Buckley M, Keating S, Xia H, Beattie S, Hamilton H, Morain CO. Omeprazole plus one or two antibiotics to eradicate H pylori. Gastroenterology. 1995; 108:63. Abstract.
39. Burette A, Glupczynski Y, DePrez C, et al. Omeprazole alone or in combination with Clarithromycin for eradication of H pylori: results of a randomized double-blind controlled study. Gastroenterology. 1993;104:49. Abstract.
40. Burette A, Glupczynski Y, Deprez C, Ramdani B. Omeprazole + amoxicillin + clarithromycin therapy for H pylori infection. Gastroenterology. 1995; 108:64. Abstract.
41. Cayla R, de Mascarel A, Zerbib F, et al. High dose of lansoprazole plus amoxicillin versus high dose of lansoprazole plus amoxicillin and Clarithromycin for Helicobacter pylori (H pylori) infection. Gastroenterology. 1995;108: 1367. Abstract.
42. Cayla R, Zerbib F, de Mascarel A, et al. High dose of lansoprazole in combination with amoxicillin and Clarithromycin twice daily for H pylori eradication: results of a pilot study. Am J Gastroenterol. 1994;89:1367. Abstract.
43. 2 antagonist treatment and the evaluation of eradication using standard 'triple' therapy compared with omeprazole and amoxycillin: a study in a single general practice. Br Soc Gastroenterol. 1993;34(suppl T145):S37.
44. de Boer WA, Driessen WMM, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet. 1995;345: 817-820.
45. de Boer WA, Driessen WMM. Dual therapy of omeprazole plus amoxicillin versus quadruple therapy of omeprazole bismuth, tetracycline and metronidazole for cure of H pylori infection in ulcer patients. Gastroenterology. 1995; 108:80. Abstract.
46. de Boer WA, Driessen WMM, Potters HVPJ, Tytgat GNJ. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol. 1994;89:1993-1997.
47. Forné M, Viver JM, Espinós JC, Coll I, Tresserra F, Garau J. Impact of colloidal bismuth subcitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and Clarithromycin: a randomized study. Am J Gastroenterol. 1995;90:718-721.
48. Goh KL, Peh SC, Parasakthi N, Wong NW, Tan KK, Lo YL. Omeprazole 40 mg OM combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori. Am J Gastroenterol. 1994;89:1789-1792.
49. Graham KS, Malaty H, El-Zimaity HMT, et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol. 1995;90:1415-1418.
50. Harris AW, Gummett PA, Logan RPH, Ashworth HM, Baron JH, Misiewicz JJ. Eradication of Helicobacter pylori with lansoprazole and clarithromycin. Aliment Pharmacol Ther. 1995;9:201-204.
51. Hirschowitz BJ, Mohnen J, Shaw S. Omeprazole with amoxicillin alone or with clarithromycin to treat H pylori. Gastroenterology. 1995;108:115. Abstract.
52. Hoffenberg P, Reyes V, Contreras L, Giglio M, Ossa P, Weitz JC. Comparison of 2 treatment schemes to eradicate Helicobacter pylori. Rev Med Chil. 1995; 123:185-191.
53. Hosking SW, Ling TKW, Chjung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994;343:508-510.
54. Hosking SW, Ling TKW, Yung ML, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ. 1992;398:502-504.
55. Hudson N, Brydon G, Eastwood MA, Ferguson A, Palmer KR. Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen. Aliment Pharmacol Ther. 1995;9:47-50.
56. Hunt R, Schwartz H, Fitch D, Fedorak R, AI Kawas F, Vakil N. Dual therapy of clarithromycin (CL) and omeprazole (OM) for treatment of patients with duodenal ulcers (DU) associated with H pylori (HP) infection. Gastroenterology. 1995;108:118. Abstract.
57. Iser JH, Buttigieg RJ, Iseli A. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer. Med J Aust 1994;160:192-196.
58. Jaup BH, Norrby A. Comparison of two low dose one-week triple therapy regimens with and without metronidazole for cure of H pylori infection. Gut. 1995;37(suppl 1):92. Abstract.
59. Jonas C, Van Gossum V, De Koster E, Deltenre M. Healing GD ulcer with a two weeks treatment course. Gastroenterology. 1995;108:125. Abstract.
60. Katelaris PH, Patchett SE, Zhang ZW, Domizio P, Farthing MJG. A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. Aliment Pharmacol Ther. 1995;9:205-208.
61. Kiyomizu T, Akamizu Y, Fujimori T, et al. Eradication of Helicobacter pylori and trends in serum antibody titers: clinical significance of serum antibody titers [in Japanese]. Shinyaku to Rinsho. 1994;43:165-171.
62. Labenz J, Gyenes E, Rühl GH, Börsch G. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut 1993;34:1167-1170.
63. Labenz J, Gyenes E, Rühl GH, Börsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol. 1993;88:491-494.
64. Labenz J, Gyenes E, Rühl GH, Börsch G. Two weeks treatment with amoxicillin/ omeprazole for eradication of Helicobacter pylori. Z Gastroenterol. 1992;30:776-778.
65. Labenz J, Rühl GH, Bertrams J, Börsch G. Clinical course of duodenal ulcer disease one year after omeprazole plus amoxycillin or triple therapy plus ranitidine for cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1994;6:293-297.
66. Labenz J, Rühl GH, Bertrams J, Börsch G. Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease. Dig Dis Sci. 1994;39:1483-1487.
67. Labenz J, Stolte M, Rühl GH, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1995; 7:9-11.
68. Lahaie RG, Lemoyne M, Poitras M, et al. A randomized trial of the efficacy of three regimens for the eradication of Helicobacter pylori. Gastroenterology. 1995;108:141. Abstract.
69. Lambert JR, Lin SK, Borromeo M, et al. Eradication of Helicobacter pylori with colloidal bismuth subcitrate/antibiotic combinations. Gastroenterology. 1990;98(pt 2):74. Abstract.
70. Lind T, Veldhuyzen van Zante SJO, Unge P, et al. The MACH 1 Study: optimal one-week treatment for H pylori defined? Gut. 1995;37(suppl 1):4. Abstract.
71. Logan RPH, Gummett PA, Hegarty BT, Walker MM, Baron JH, Misiewicz JJ. Clarithromycin and omeprazole for Helicobacter pylori. Lancet. 1992;340:239.
72. Logan RPH, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut. 1994;35:323-326.
73. Londong W, Gorgas R, Pommerien U, et al. Effect of different omeprazole doses combined with amoxicillin on intragastric pH, amoxicillin bioavailability and Helicobacter pylori eradication in duodenal ulcer patients. Gastroenterology. 1995;8:153. Abstract.
74. Louw JA, Zak J, Lucke W, et at. Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates. Scand J Gastroenterol Suppl. 1992; 27(suppl 191):28-31.
75. Mantzaris GJ, Hatzis A, Tamvakologos G, et al. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers: healing and long-term relapse rates. Dig Dis Sci. 1993;38:1132-1136.
76. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, Langworthy H. One week low-dose triple therapy for eradication of H pylori: a large multicentre randomised trial. In: Program and abstracts of the American Gastroenterological Association and American Association for the Study of Liver Disease; May 19-22, 1996; San Francisco, Calif. Abstract.
77. Moayyedi P, Tompkins DS, Axon ATR. Efficacy of ten days of clarithromycin, amoxicillin and omeprazole in eradicating Helicobacter pylori infection. Gastroenterology. 1995;108:169. Abstract.
78. Moayyedi P, Tompkins DS, Shanaghan K, et al. Comparison of one and two weeks of lansoprazole, amoxycillin and clarithromycin in eradicating Helicobacier pylori. Gut. 1995;37(suppl 2):7. Abstract.
79. Mohamed H, Chiba N, Wilkinson J, Hunt R. Eradication of Helicobacter pylori. Gastroenterology. 1994;106:142. Abstract.
80. 13C-UBTand monoclonal H pylori antibody testing. J Clin Gastroenterol. 1995;20(suppl 2):118-120.
81. Neves B, Vá S, Duarte C, Quina M. Amoxicillin/omeprazole versus amoxicillin/ omeprazole/clarithromycin for eradication of H pylori. Gastroenterology. 1995; 108:177. Abstract.
82. O'Connor HJ, Kanduru C, Bhutta AS, Meehan JM, Feeley KM, Cunnane K. Effect of Helicobacter pylori eradication on peptic ulcer healing. Postgrad Med J. 1995;71:90-93.
83. O'Riordian T, Mathai E, Tobin E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut. 1990;31:999-1002.
84. Patchett S, Beattie S, Leen E, et al. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ. 1991;303:1238-1240.
85. Phillips P. Omeprazole/clarithromycin combo eradicates H pylori. Med Trib. Novembers, 1994:4.
86. Phull PS, Price AB, Halliday D, et al. Lansoprazole plus clarithromycin: evaluation of a new dual therapy for H pylori eradication. Gastroenterology. 1995; 108:191. Abstract.
87. Pilotto A, Franceshi M, Bozzola L, et al. The cure for Helicobacter pylori (HP) infection with double or triple omeprazole-based therapies in the elderly: effects on eradication rate, chronic gastritis and serum anti-HP antibodies and pepsinogens. Gastroenterology. 1995;108:192. Abstract.
88. Pryce D, Harris AW, Gabe SM, et al. One week of lansoprazole, clarithromycin and metronidazole eradicates Helicobacter pylori. In: Program and abstracts of the American Gastroenterological Association and American Association for the Study of Liver Disease; May 19-22, 1996; San Francisco, Calif. Abstract.
89. Saberi-Firoozi M, Massarrat S, Zare S, et al. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study. Am J Gastroenterol. 1995;90:1419-1423.
90. Salandin S, Battaglia G, Dal Bo N, et al. Clarithromycin for the cure of Helicobacter pylori infection: one or two weeks of treatment. Gastroenterology. 1995;108:207. Abstract.
91. Schaufelberger HD, Logan RPH, Gummett PA, Baron JH, Misiewicz JJ. The effect of patient compliance on Helicobacter pylori (H pylori) eradication with dual therapy, II. In: United European Gastroenterology Week. Barcelona, Spain: BMJ Publishing Group; July 19-24, 1993;98.
92. Schaufelberger HD, Logan RPH, Misiewicz JJ, et al. The dose and frequency of omeprazole are important in treating H pylori with dual therapy. Gastroenterology. 1993;104:186. Abstract.
93. Sierra F, Gutierrez O, Molano B, Ricaurte O, Otero W. Eradication of Helicobacter pylori with lansoprazole and clarithromycin. Gastroenterology. 1995; 108:219. Abstract.
94. Soulé JC, Courrier A, Bigard MA, et al. Efficacy of lansoprazole plus one or two antibiotics for Helicobacter pylori eradication. Gastroenterology. 1995; 108:224. Abstract.
95. Spencer CM, Faulds D. Lansoprazole: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs. 1994;48:405-430.
96. Spiliadis C, Georgopoulos S, Stambolos P, et al. Evaluation of the efficacy of clarithromycin in the eradication of Helicobacter pylori. Gastroenterology. 1995; 108:225. Abstract.
97. Sung JJY, Chung SCS, Ling TKW, et al. One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori. Am J Gastroenterol. 1994; 89:199-202.
98. Thijs JC, Van Zwet AA, Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol. 1993; 28:934-938.
99. Truesdale RA, Chamberlain CE, Martin DF, et al. Long-term follow-up and antibody response to treatment of patients with Helicobacter pylori. Gastroenterology. 1990;98:140. Abstract.
100. Unge P, Gad A, Eriksson K, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol. 1993;5:325-331.
101. Wang W-M, Chen C-Y, Jan C-M, et al. Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers. J Formos Med Assoc. 1993; 92:721-724.
102. Wilde MI, McTavish D. Omeprazole: an update of its pharmacology and therapeutic use in acid-related disorders. Drugs. 1994;48:92-127.
103. Xia H, Daw MA, Sant S, Beattie S, Keane CT, O'Morain CA. Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer. Eur J Gastroenterol Hepatol. 1993;5:141-144.
104. Yousfi MM. Metronidazole, omeprazole and clarithromycin (MOC): an effective combination therapy for Helicobacter pylori infection. Gastroenterology. 1995;108:265. Abstract.
105. Bio-Rad Laboratories. Bridging the Gap: Gastritis and Peptic Ulcers Testing for H pylori Antibodies. Hercules, Calif: Bio Rad Diagnostics Group; 1993:3.
106. BioWhittaker, Inc. EIA Test System: Pylori ELISA II. Walkersville, Md: BioWhittaker Inc; May 1995.
107. Enteric Products Incorporated. HM CAP: Helicobacter pylori Immunoassay. Stony Brook, NY: Enteric Products Inc; 1994.
108. Hycor Biomedical Inc. Pyloragen: An Enzyme Immunoassay for the Detection of IgG and IgA Antibodies to Helicobacter pylori in Human Serum. Irvine, Calif: Hycor Biomedical Inc; 1995.
109. Tytgat GNJ, Noach LA, Rauws EAJ. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am. 1993;22:127-139.
110. Elashoff JD, Van Deventer GM, Reedy TJ, et al. Long-term follow-up of duodenal ulcer patients. J Clin Gastroenterol. 1983;5:509-515.
111. Van Deventer GM, Elashoff JD, Reedy TJ, Schneidman D, Walsh JH. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med. 1989;320:1113-1119.
112. Wade AG, Rowley-Jones D. Long term management of duodenal ulcer in general practice: how best to use cimetidine? BMJ. 1988;296:971-974.
113. 2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori. J Formos Med Assoc. 1994; 93:368-372.
114. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988; 2:1437-1442.
115. Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993;328:308-312.
116. Bianchi Porro GB, Parente F, Lazzaroni M. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralphate alone. Gut. 1993;34:466-469.
117. Patchett S, Beattie S, Leen E, Keane C, O'Morain C. Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol. 1992;87:24-27.
118. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. 1992; 87:1716-1727.
119. Treiber G. The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. Am J Gastroenterol. 1996;91:246-257.
120. Labenz J, Rühl GH, Bertrams J, Börsch G. Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease. Aliment Pharmacol Ther. 1994;8:323-327.
121. Health Care Financing Review. Baltimore, Md: US Dept of Health and Human Services; 1995;17:304-305.
122. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making. 1985;5:157-177.
123. Lipton J, Shaw WD, Holmes J, Patterson A. Short communication: selecting input distributions for use in Monte Carlo simulations. Regul Toxicol Pharmacol. 1995;21:192-198.